Regeneron was up 4.7% at $813.38. If the gains hold, the stock will notch its highest close since Nov. 12, 2024, when it ...
As 2026 begins, a slate of high-stakes clinical readouts—from a pivotal study of Novartis’ cardiovascular candidate ...
ETHealthworld.com brings latest healthcare news, views and updates. Get healthcare industry & sector news from all top sources for the Indian Health industry.